 |
Top 10 Startups developing AI for Medicine and Healthcare
Updated: March 21, 2024 |
Artificial intelligence (AI) in Medicine is used for diagnosis processes, treatment protocol development, drug development, personalized medicine,and patient monitoring and care.
1
Country: USA | Funding: $1.3B
Tempus is a technology company that is building the world's largest library of molecular and clinical data and an operating system to make that data accessible and to battle cancer.
Tempus is a technology company that is building the world's largest library of molecular and clinical data and an operating system to make that data accessible and to battle cancer.
2
Country: UK | Funding: $1.2B
Babylon is a subscription health service provider that enables users to have virtual consultations with doctors and health care professionals via text and video messaging through its mobile application. Babylon app also uses AI to answer questions you normally ask your family doctor.
Babylon is a subscription health service provider that enables users to have virtual consultations with doctors and health care professionals via text and video messaging through its mobile application. Babylon app also uses AI to answer questions you normally ask your family doctor.
3
Country: UK
Google's DeepMind is the world leader in artificial intelligence research and its application in different fields, like games, medicine, energy efficiency.
Google's DeepMind is the world leader in artificial intelligence research and its application in different fields, like games, medicine, energy efficiency.
4
Country: USA | Funding: $1.1B
Freenome is connecting patients with next-generation cancer screening and diagnostic tests through the power of artificial intelligence.
Freenome is connecting patients with next-generation cancer screening and diagnostic tests through the power of artificial intelligence.
5
Country: USA | Funding: $974.1M
Zymergen uses machine learning to discover and engineers microbe genomes to produce new molecular products for new materials.
Zymergen uses machine learning to discover and engineers microbe genomes to produce new molecular products for new materials.
6
Country: USA | Funding: $902M
Olive uses Artificial Intelligence to allow healthcare organizations automate a variety of tasks including order management, eligibility, prior authorizations, claims processing, and more. AI doesn’t compromise the IT infrastructure you already have in place—instead, it helps you run the tools you already have more efficiently.
Olive uses Artificial Intelligence to allow healthcare organizations automate a variety of tasks including order management, eligibility, prior authorizations, claims processing, and more. AI doesn’t compromise the IT infrastructure you already have in place—instead, it helps you run the tools you already have more efficiently.
7
Country: USA | Funding: $743M
Insitro is a machine-learning driven drug discovery and development company.
Insitro is a machine-learning driven drug discovery and development company.
8
Country: USA | Funding: $665.4M
Drug discovery, reimagined through Artificial Intelligence. We are discovering transformative new treatments by leveraging the speed of automation with the intelligence of computers. It’s drug discovery at unprecedented pace.
Drug discovery, reimagined through Artificial Intelligence. We are discovering transformative new treatments by leveraging the speed of automation with the intelligence of computers. It’s drug discovery at unprecedented pace.
9
Country: UK | Funding: $474.4M
Exscientia is applying AI and big data processing to accelerate drug discovery and development.
Exscientia is applying AI and big data processing to accelerate drug discovery and development.
10
Country: Singapore | Funding: $463.6M
Biofourmis is reinventing remote patient monitoring by detecting personalized patterns predictive of patient’s health deterioration
Biofourmis is reinventing remote patient monitoring by detecting personalized patterns predictive of patient’s health deterioration
Ad
Advertise your startup
11
Country: USA | Funding: $457M
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems.
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems.
12
Country: South Korea | Funding: $438.2M
Lunit builds data-driven imaging biomarker (DIB) technology for image-based disease screening.
Lunit builds data-driven imaging biomarker (DIB) technology for image-based disease screening.
13
Country: Hong Kong | Funding: $401.3M
Artificial Intelligence for Drug Discovery and Aging Research.
Artificial Intelligence for Drug Discovery and Aging Research.
14
Country: USA | Funding: $366.5M
Spring uses AI to help patients with mental health problems feel better faster. The startup operates as an online mental health clinic for employers, using proprietary machine-learning technology to provide personalized treatment recommendations with hopes that they will be more effective.
Spring uses AI to help patients with mental health problems feel better faster. The startup operates as an online mental health clinic for employers, using proprietary machine-learning technology to provide personalized treatment recommendations with hopes that they will be more effective.
15
Country: USA | Funding: $355.2M
PathAI's goal is to improve cancer diagnosis using artificial intelligence. PathAI’s services solve the most challenging pathology problems faced by the research and pharmaceutical industry.
PathAI's goal is to improve cancer diagnosis using artificial intelligence. PathAI’s services solve the most challenging pathology problems faced by the research and pharmaceutical industry.
16
Country: USA | Funding: $330.3M
K Health has built the first HIPAA compliant AI health app 100% fueled by data, empowering users worldwide to take control of their health. By working with a unique data set of over a billion health interactions, K Health is able to generate better and more accurate insights based on PLM (a.k.a. “People Like Me”), a new approach to understanding our health that looks at other people like us who have had similar experiences.
K Health has built the first HIPAA compliant AI health app 100% fueled by data, empowering users worldwide to take control of their health. By working with a unique data set of over a billion health interactions, K Health is able to generate better and more accurate insights based on PLM (a.k.a. “People Like Me”), a new approach to understanding our health that looks at other people like us who have had similar experiences.
17
Country: USA | Funding: $328M
Clarify Health Solutions develops AI analytics software solutions that enable health systems to deliver more satisfying, better outcome and higher value care
Clarify Health Solutions develops AI analytics software solutions that enable health systems to deliver more satisfying, better outcome and higher value care
18
Country: USA | Funding: $324.9M
Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. It uses machine-learning algorithms to analyse the world’s largest real-world oncology data source.
Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. It uses machine-learning algorithms to analyse the world’s largest real-world oncology data source.
19
Country: Portugal | Funding: $323.5M
SWORD Health is a medical company that created the first AI-powered digital physical therapist, shifting healthcare from analog to digital.
SWORD Health is a medical company that created the first AI-powered digital physical therapist, shifting healthcare from analog to digital.
20
Country: France | Funding: $304.1M
OWKIN is the AI startup that uses machine learning to augment medical and biology research. Its proprietary platform, OWKIN Socrates, uses machine learning technology to integrate biomedical images, genomics and clinical data to discover biomarkers and mechanisms associated with diseases and treatment outcomes.
OWKIN is the AI startup that uses machine learning to augment medical and biology research. Its proprietary platform, OWKIN Socrates, uses machine learning technology to integrate biomedical images, genomics and clinical data to discover biomarkers and mechanisms associated with diseases and treatment outcomes.
21
Country: USA | Funding: $300M
ConcertAI, a real-world data and artificial intelligence startup for healthcare providers and life science companies
ConcertAI, a real-world data and artificial intelligence startup for healthcare providers and life science companies
22
Country: USA | Funding: $295M
Immunai is a biotech company that combines single cell genomics with ML algorithms to enable high resolution profiling of the immune system.
Immunai is a biotech company that combines single cell genomics with ML algorithms to enable high resolution profiling of the immune system.
23
Country: UK | Funding: $292M
BenevolentAI is applying artificial intelligence to develop new medicines for hard to treat diseases. It is the first fully integrated AI company with pharmaceutical discovery and clinical development capabilities. BenevolentAI’s advanced technology is disrupting the pharmaceutical industry by lowering costs, decreasing failure rates and increasing the speed at which medicines are delivered to patients.
BenevolentAI is applying artificial intelligence to develop new medicines for hard to treat diseases. It is the first fully integrated AI company with pharmaceutical discovery and clinical development capabilities. BenevolentAI’s advanced technology is disrupting the pharmaceutical industry by lowering costs, decreasing failure rates and increasing the speed at which medicines are delivered to patients.
24
Country: USA | Funding: $291.6M
Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
25
Country: USA | Funding: $278.1M
InterVenn Biosciences combined the molecular-level resolution of mass spectrometry with the throughput of artificial intelligence to create a unique platform to discover new biomarkers, provide more effective treatments, design precision medicine trials, and pursue novel targets.
InterVenn Biosciences combined the molecular-level resolution of mass spectrometry with the throughput of artificial intelligence to create a unique platform to discover new biomarkers, provide more effective treatments, design precision medicine trials, and pursue novel targets.
26
Country: Israel | Funding: $267.5M
AIdoc helps radiologists work through their case load faster, just in time to make a difference. We reworked deep learning algorithms to analyze imaging and clinical data more effectively, and can produce highly accurate scan anomaly detection. We combine the analyzed scans with patient data, streamlining the radiologists' workflow and freeing them to do what they do best.
AIdoc helps radiologists work through their case load faster, just in time to make a difference. We reworked deep learning algorithms to analyze imaging and clinical data more effectively, and can produce highly accurate scan anomaly detection. We combine the analyzed scans with patient data, streamlining the radiologists' workflow and freeing them to do what they do best.
27
Country: USA | Funding: $257.8M
Well Dot is an artificial intelligence startup that uses data and behavioral economics to provide daily health recommendations
Well Dot is an artificial intelligence startup that uses data and behavioral economics to provide daily health recommendations
28
Country: USA | Funding: $256.1M
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines
29
Country: France | Funding: $250.2M
Sophia Genetics developed SOPHiA, a collective artificial intelligence for clinical genomics, helping healthcare professionals better diagnose and treat patients.
Sophia Genetics developed SOPHiA, a collective artificial intelligence for clinical genomics, helping healthcare professionals better diagnose and treat patients.
30
Country: USA | Funding: $237.9M
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
31
Country: Canada | Funding: $236.7M
Deep Genomics brings together world-leading expertise in machine learning and genome biology. We’re inventing a new generation of computational technologies that predict what will happen within a cell when DNA is altered by genetic variation, whether natural or therapeutic. Our systems predict the molecular effects of genetic variation, opening a new and exciting path to discovery for disease diagnostics and therapies.
Deep Genomics brings together world-leading expertise in machine learning and genome biology. We’re inventing a new generation of computational technologies that predict what will happen within a cell when DNA is altered by genetic variation, whether natural or therapeutic. Our systems predict the molecular effects of genetic variation, opening a new and exciting path to discovery for disease diagnostics and therapies.
32
Country: USA | Funding: $222M
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
33
Country: USA | Funding: $220M
Paige.AI, stands for Pathology AI Guidance Engine, is a new startup that uses artificial intelligence to fight cancer. The company focus on breast, prostrate and other major cancers, and expects to partner with other medical centers beyond MSK, as well as commercial labs and pharmaceutical companies as it grows and develops its applications.
Paige.AI, stands for Pathology AI Guidance Engine, is a new startup that uses artificial intelligence to fight cancer. The company focus on breast, prostrate and other major cancers, and expects to partner with other medical centers beyond MSK, as well as commercial labs and pharmaceutical companies as it grows and develops its applications.
34
Country: USA | Funding: $207.5M
Caresyntax is a digital surgery platform that uses proprietary software and AI to deliver actionable insights to improve patient outcomes.
Caresyntax is a digital surgery platform that uses proprietary software and AI to deliver actionable insights to improve patient outcomes.
35
Country: Germany | Funding: $189.5M
Ada Health offers a new approach to personalized health, supported by a sophisticated artificial intelligence technology. Ada its conversational health assistant to empower people with personalized medical insights and identify appropriate next steps.
Ada Health offers a new approach to personalized health, supported by a sophisticated artificial intelligence technology. Ada its conversational health assistant to empower people with personalized medical insights and identify appropriate next steps.
36
Country: USA | Funding: $176.6M
Atomwise is the creator of AtomNet, the first Deep Learning technology for novel small molecule discovery, characterized by its unprecedented speed, accuracy, and diversity.
Atomwise is the creator of AtomNet, the first Deep Learning technology for novel small molecule discovery, characterized by its unprecedented speed, accuracy, and diversity.
37
Country: USA | Funding: $173.4M
IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. The company’s first product, IDx-DR, is an FDA-cleared AI-based diagnostic system designed for use at the front lines of care to detect diabetic retinopathy. IDx is developing additional AI-based diagnostic algorithms for the detection of macular degeneration, glaucoma, Alzheimer’s disease, cardiovascular disease, and stroke risk.
IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. The company’s first product, IDx-DR, is an FDA-cleared AI-based diagnostic system designed for use at the front lines of care to detect diabetic retinopathy. IDx is developing additional AI-based diagnostic algorithms for the detection of macular degeneration, glaucoma, Alzheimer’s disease, cardiovascular disease, and stroke risk.
38
Country: China | Funding: $157.4M
Synyi develops hospital informatics platform with AI capabilities
Synyi develops hospital informatics platform with AI capabilities
39
Country: USA | Funding: $152.7M
nference Artificial Intelligence AI technology (nferX) enables Knowledge Synthesis from unstructured text & structured biomedical databases.
nference Artificial Intelligence AI technology (nferX) enables Knowledge Synthesis from unstructured text & structured biomedical databases.
40
Country: USA | Funding: $128.2M
Eko creates FDA approved software, AI, and heart sound and EKG sensors for heart disease monitoring.
Eko creates FDA approved software, AI, and heart sound and EKG sensors for heart disease monitoring.
41
Country: Germany | Funding: $125M
Kaia Health is a digital therapeutics company focused on AI-powered management of chronic pain
Kaia Health is a digital therapeutics company focused on AI-powered management of chronic pain
42
Country: Israel | Funding: $123.8M
Sight Diagnostics aims to bring affordable, scalable and accurate blood diagnostics to the point-of-care, thereby accelerating better patient outcomes and improving healthcare for all. Sight has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its proprietary machine-vision technology.
Sight Diagnostics aims to bring affordable, scalable and accurate blood diagnostics to the point-of-care, thereby accelerating better patient outcomes and improving healthcare for all. Sight has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its proprietary machine-vision technology.
43
Country: Japan | Funding: ¥13.6B
AI Medical Service is developing AI software to help detect gastric cancer
AI Medical Service is developing AI software to help detect gastric cancer
44
Country: Australia | Funding: $121.1M
Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients.
Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients.
45
Country: USA | Funding: $119.2M
Notable uses AI to automate and digitize every physician-patient interaction. It automtes recording of doctor’s visits and updating of electronic health records. The company has developed a technology that uses natural language processing and voice recognition to automatically record doctor-patient interactions and structure the data for inclusion in a patient’s medical records.
Notable uses AI to automate and digitize every physician-patient interaction. It automtes recording of doctor’s visits and updating of electronic health records. The company has developed a technology that uses natural language processing and voice recognition to automatically record doctor-patient interactions and structure the data for inclusion in a patient’s medical records.
46
Country: Israel | Funding: $118.5M
IBEX develops a product suite to improve clinical decision-making and to streamline pathology laboratory workflows. AI-based cancer diagnostics.
IBEX develops a product suite to improve clinical decision-making and to streamline pathology laboratory workflows. AI-based cancer diagnostics.
47
Country: USA | Funding: $118M
Hippocratic AI’s Aim is to develop the safest artificial Health General Intelligence (HGI).
Hippocratic AI’s Aim is to develop the safest artificial Health General Intelligence (HGI).
48
Country: USA | Funding: $100.4M
Activ Surgical is building a hardware-agnostic platform to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence and robotics.
Activ Surgical is building a hardware-agnostic platform to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence and robotics.
49
Country: USA | Funding: $100M
RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients.
RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients.
50
Country: USA | Funding: $99.3M
BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.
BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.